Chen Peixin, Sun Wenwen, He Yayi
Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, Shanghai, China.
Tongji University, Shanghai, China.
J Thorac Dis. 2020 Aug;12(8):4014-4024. doi: 10.21037/jtd-20-1232.
With a high incidence rate and mortality rate, tuberculosis (TB) is a major public health concern worldwide. There is an urgent need to develop the rapid, reliable and affordable diagnostic test for the detection of (Mtb). Metagenomic next-generation sequencing (mNGS) showed promising values in the rapid diagnosis of clinical TB, while studies on the application of mNGS in pulmonary and extrapulmonary TB remain scarce.
In this study, we collected the results of both mNGS and culture of 70 specimens from suspected TB patients at the Shanghai Pulmonary Hospital of Tongji University. Results of GeneXpert MTB/RIF assay (Xpert) were obtained from 19 patients. We also assessed the diagnostic performance, relationship and consistency between mNGS, traditional culture method, and Xpert.
Overall, 36 of 70 suspected patients were finally diagnosed with TB. The sensitivity, specificity, positive predictive value, negative predictive value and the Youden index of mNGS in all clinical TB specimens were calculated as 66.7% (95% CI: 0.489-0.809), 97.1% (95% CI: 0.829-0.998), 96.0% (95% CI: 0.777-0.998), 73.3% (95% CI: 0.578-0.849), 63.8%, respectively. The sensitivity of mNGS was much superior to that of conventional culture method (66.7%, 95% CI: 0.489-0.809 36.1%, 95% CI: 0.213-0.538) and Xpert (76.9%, 95% CI: 0.460-0.938 61.5%, 95% CI: 0.323-0.849). In pulmonary TB cases, mNGS, culture, and Xpert all demonstrated better diagnostic capacity for TB when compared with extrapulmonary TB cases. Among all methods and sample classifications, the Youden index of parallel diagnostic test in pulmonary samples was outstanding (mNGS/culture 88.2%; mNGS/Xpert 100%). Furthermore, the correlation and concordance between mNGS and culture method in all types of specimens was statistically significant (both P<0.001).
With high sensitivity and specificity, mNGS showed remarkable diagnostic performance in various samples from suspected TB patients. Combining mNGS and culture or Xpert method had the potential for clinical application in TB.
结核病(TB)发病率和死亡率高,是全球主要的公共卫生问题。迫切需要开发快速、可靠且经济实惠的诊断测试来检测结核分枝杆菌(Mtb)。宏基因组下一代测序(mNGS)在临床结核病的快速诊断中显示出有前景的价值,而关于mNGS在肺结核和肺外结核中的应用研究仍然很少。
在本研究中,我们收集了同济大学附属上海市肺科医院70例疑似结核病患者标本的mNGS和培养结果。从19例患者中获得了GeneXpert MTB/RIF检测(Xpert)结果。我们还评估了mNGS、传统培养方法和Xpert之间的诊断性能、关系和一致性。
总体而言,70例疑似患者中有36例最终被诊断为结核病。mNGS在所有临床结核病标本中的敏感性、特异性、阳性预测值、阴性预测值和尤登指数分别计算为66.7%(95%CI:0.489 - 0.809)、97.1%(95%CI:0.829 - 0.998)、96.0%(95%CI:0.777 - 0.998)、73.3%(95%CI:0.578 - 0.849)、63.8%。mNGS的敏感性远优于传统培养方法(66.7%,95%CI:0.489 - 0.809对36.1%,95%CI:0.213 - 0.538)和Xpert(76.9%,95%CI:0.460 - 0.938对61.5%,95%CI:0.323 - 0.849)。在肺结核病例中,与肺外结核病例相比,mNGS、培养和Xpert在诊断结核病方面均表现出更好的能力。在所有方法和样本分类中,肺部样本平行诊断测试的尤登指数突出(mNGS/培养88.2%;mNGS/Xpert 100%)。此外,mNGS与培养方法在所有类型标本中的相关性和一致性具有统计学意义(均P<0.001)。
mNGS具有高敏感性和特异性,在疑似结核病患者的各种样本中显示出显著的诊断性能。mNGS与培养或Xpert方法联合在结核病临床应用中具有潜力。